Alison Slater

637 total citations
16 papers, 420 citations indexed

About

Alison Slater is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Alison Slater has authored 16 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Oncology and 3 papers in Immunology. Recurrent topics in Alison Slater's work include Drug Transport and Resistance Mechanisms (5 papers), RNA Interference and Gene Delivery (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Alison Slater is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), RNA Interference and Gene Delivery (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Alison Slater collaborates with scholars based in Australia, United Kingdom and United States. Alison Slater's co-authors include Xiu Feng Hu, John Parkin, Phillip Kantharidis, John Zalcberg, William T. Melvin, Dominic Wall, Hamish Allen, Assam El‐Osta, Lesley W. Coggins and Surender Juneja and has published in prestigious journals such as Nucleic Acids Research, Blood and Scientific Reports.

In The Last Decade

Alison Slater

16 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alison Slater Australia	10	309	153	48	44	29	16	420
Aloke Sarkar United States	14	273 0.9×	105 0.7×	56 1.2×	65 1.5×	29 1.0×	20	492
Martijn Schoester Netherlands	11	309 1.0×	235 1.5×	95 2.0×	28 0.6×	20 0.7×	13	484
Emine A. Ercikan-Abali United States	9	224 0.7×	121 0.8×	40 0.8×	21 0.5×	61 2.1×	12	342
Chiel Maas Netherlands	13	342 1.1×	104 0.7×	50 1.0×	20 0.5×	46 1.6×	14	444
Caroline Smal Belgium	12	230 0.7×	110 0.7×	25 0.5×	114 2.6×	14 0.5×	22	333
Kai-Hsin Chang United States	5	147 0.5×	79 0.5×	83 1.7×	99 2.3×	45 1.6×	12	305
Andrea Baines United States	9	165 0.5×	89 0.6×	42 0.9×	16 0.4×	65 2.2×	11	449
Sarah Scotland United States	6	240 0.8×	66 0.4×	40 0.8×	64 1.5×	19 0.7×	10	435
HL Liu China	6	156 0.5×	101 0.7×	49 1.0×	21 0.5×	75 2.6×	9	421
Gabriele Greve Germany	10	368 1.2×	92 0.6×	148 3.1×	25 0.6×	30 1.0×	19	467

Countries citing papers authored by Alison Slater

Since Specialization

Citations

This map shows the geographic impact of Alison Slater's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Slater with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Slater more than expected).

Fields of papers citing papers by Alison Slater

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Slater. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Slater. The network helps show where Alison Slater may publish in the future.

Co-authorship network of co-authors of Alison Slater

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Slater. A scholar is included among the top collaborators of Alison Slater based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Slater. Alison Slater is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

1.

Slater, Alison, et al.. (2022). Age-related fertility decline and elective oocyte cryopreservation: Knowledge, attitudes and practices in a pilot study of general practitioners. Australian Journal of General Practice. 51(8). 611–619. 8 indexed citations

2.

Lau, Peter K. H., Carleen Cullinane, Susan Jackson, et al.. (2021). Enhancing Adoptive Cell Transfer with Combination BRAF-MEK and CDK4/6 Inhibitors in Melanoma. Cancers. 13(24). 6342–6342. 6 indexed citations

3.

AbuHammad, Shatha, Alison Slater, Laura Kirby, et al.. (2021). CDK4/6 Inhibition Reprograms Mitochondrial Metabolism in BRAFV600 Melanoma via a p53 Dependent Pathway. Cancers. 13(3). 524–524. 16 indexed citations

4.

Lelliott, Emily J., Stefano Mangiola, Kelly M. Ramsbottom, et al.. (2020). Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in Melanoma. Cancer Immunology Research. 9(2). 136–146. 15 indexed citations

5.

Lelliott, Emily J., Carleen Cullinane, Claire Martin, et al.. (2019). A novel immunogenic mouse model of melanoma for the preclinical assessment of combination targeted and immune-based therapy. Scientific Reports. 9(1). 1225–1225. 17 indexed citations

6.

Khan, Mohidus Samad, et al.. (2010). Effect of polymers on the retention and aging of enzyme on bioactive papers. Colloids and Surfaces B Biointerfaces. 79(1). 88–96. 18 indexed citations

7.

Hu, Xiu Feng, Alison Slater, Phillip Kantharidis, et al.. (1999). Altered Multidrug Resistance Phenotype Caused by Anthracycline Analogues and Cytosine Arabinoside in Myeloid Leukemia. Blood. 93(12). 4086–4095. 6 indexed citations

8.

Hu, Xiu Feng, Alison Slater, Phillip Kantharidis, et al.. (1999). Altered Multidrug Resistance Phenotype Caused by Anthracycline Analogues and Cytosine Arabinoside in Myeloid Leukemia. Blood. 93(12). 4086–4095. 54 indexed citations

9.

Kantharidis, Phillip, Assam El‐Osta, Dominic Wall, et al.. (1997). Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance.. PubMed. 3(11). 2025–32. 123 indexed citations

10.

Hu, Xiu Feng, Alison Slater, Dominic Wall, et al.. (1996). Cyclosporin A and PSC 833 prevent up-regulation of MDR1 expression by anthracyclines in a human multidrug-resistant cell line.. PubMed. 2(4). 713–20. 17 indexed citations

11.

Zalcberg, John, Xiu Feng Hu, Alison Slater, et al.. (1994). Rapid but differential upregulation of MDR1 expression by anthracyclines in a classical drug resistant cell line. Anti-Cancer Drugs. 5. 6–6. 1 indexed citations

12.

Coggins, Lesley W., et al.. (1985). Sequence homologies between bovine papillomavirus genomes mapped by a novel low-stringency heteroduplex method. Virology. 143(2). 603–611. 6 indexed citations

13.

Coggins, Lesley W., W. George Lanyon, Alison Slater, Guillermo Grindlay, & John Paul. (1981). Characterization of Alu family repetitive sequences which flank human β-type globin genes. Bioscience Reports. 1(4). 309–317. 4 indexed citations

14.

Coggins, Lesley W., Guillermo Grindlay, J. Keith Vass, et al.. (1980). Repetitive DNA sequences near three humanβ-type globin genes. Nucleic Acids Research. 8(15). 3319–3333. 31 indexed citations

15.

Melvin, William T., et al.. (1979). Effect of amino acid deprivation on DNA synthesis in BHK‐21/C13 cells. Journal of Cellular Physiology. 98(1). 73–79. 12 indexed citations

16.

Melvin, William T., et al.. (1978). Incorporation of 6‐Thioguanosine and 4‐Thiouridine into RNA. European Journal of Biochemistry. 92(2). 373–379. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact